Our team has assembled a list of frequently asked questions to help you find answers quickly. Filter using one or more categories to focus on specific topics, or use the search bar to perform a text search.
Yes, the IMMUNOVerse BCR panel can detect somatic hypermutation relevant for determining subsets of cancer cell populations helpful in chronic lymphocytic leukemia (CLL) characterization. Gene specific primers bind the constant region of the B-cell receptor mRNA transcript and allow for amplification of the V(D)J region, including hypermutated V regions, and Archer™ Analysis reports hypermutation status for the most highly represented clonotypes.